Marianne Habdank

Statistics

Publications

Citations

4.8K

H-Index

Active since

2005

Affiliations

University Hospital Ulm(Current)

Heidelberg University

German Cancer Research Center

University of Freiburg

University Medical Center Freiburg

Marianne Habdank is an author at University Hospital Ulm specializing in cancer cytogenetics, acute myeloid leukemia biology, and leukemia cytogenetics.

Publications per year

2005–2016

Publications

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

Richard F. Schlenk, Konstanze Döhner, Jürgen Krauter et al. · New England Journal of Medicine · 2008 · 1.6K citations

Life Sciences, Genetics, Molecular Genetics +17

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

Konstanze Döhner, Richard F. Schlenk, Marianne Habdank et al. · Blood · 2005 · 845 citations · Full text

Life Sciences, Genetics, Oncology +11

IDH1andIDH2Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia WithNPM1Mutation WithoutFLT3Internal Tandem Duplication

Peter Paschka, Richard F. Schlenk, Verena I. Gaidzik et al. · Journal of Clinical Oncology · 2010 · 791 citations

Life Sciences, Genetics, Hematology +16

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

Frank G. Rücker, Richard F. Schlenk, Lars Bullinger et al. · Blood · 2011 · 678 citations · Full text

Life Sciences, Genetics, Oncology +17

Monitoring of Minimal Residual Disease in NPM1 -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group

Jan Krönke, Richard F. Schlenk, Kai‐Ole Jensen et al. · Journal of Clinical Oncology · 2011 · 394 citations · Full text

Medicine, Hematology, Oncology +15

1–5 of 10